Tracking records of big price movements since September 9th 2021:
(Scroll LEFT and RIGHT to see full TABLE)
| Date | Sentiment | What Happened? | Last Price On That Closing Day | Percentage of Price Changes | Reference |
| Sep 09, 2021 | Negative | FDA has declined Humanigen’s Emergency Use Authorization (EUA) Request for Lenzilumab in Hospitalized COVID-19 Patients | $7.9700 | -47.25% | LINK |
